Comparison of Effects and Safety of Coenzyme A and Fenofibrate in Patients with Dyslipidemia

赵水平,陈雅琴,陈君柱,来江涛

2013-01-01

Abstract:AIM To compare the effects of coenzyme A(CoA) and pantethine on plasma lipid levels in Chinese patients with moderate hyperlipidemia.METHODS In the prospective,randomized,double-blind, multi-centre,phaseⅢclinical trial,223 patients with hyperlipidemia(triglyceride(TG) 2.3 - 6.5 mmol·L~(-1)) were randomly received CoA 400 U·d~(-1)(po,n = 118) and pantethine 600 mg·d~(-1)(po,n =118) for 8 weeks. After 4 weeks and 8 weeks,blood routine,urine routine,hepatic function,renal function,blood glucose, blood lipid and creatine kinase were measured.The primary end point was the percentage change in TG from baseline to 4 weeks and 8 weeks,and the secondary efficacy parameters were variation rates of plasma total cholesterol(TC),low - density lipoprotein cholesterol(LDL - C) and high - density lipoprotein cholesterol (HDL-C).Adverse events were compared in two groups after the treatment.RESULTS After the treatment for 4 weeks,TG levels of the CoA group and the pantethine group were reduced 26.0%and 17.4%respectively, with 33.3%and 16.5%after 8 weeks treatment.The difference between two groups was significant(P0.01). Compared with the pantethine group,the reduction rate of TC in the CoA group was higher(P0.05).After the treatment,there was no significant difference of LDL-C and HDL-C between two groups(P0.05).There was also no significant difference of drug - related adverse event rates between two groups(P0.05). CONCLUSIONS CoA 400 U·d~(-1) and pantethine 600 mg·d~(-1) had the effect on lowing TG with good safety and tolerance in the moderate hyperlipidemia patients,and CoA was better than pantethine.